Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Implementera, utvärdera och skala upp programmet för att stärka ett palliativt tillvägagångssätt inom långtidsvård (SPA-LTC)

5 oktober 2026 uppdaterad av: McMaster University

This study will evaluate the implementation of the Strengthening a Palliative Approach in Long-Term Care (SPA-LTC) program using a cross-jurisdictional, effectiveness-implementation type II hybrid design (dual testing of clinical and implementation interventions) to assess the implementation (feasibility, fidelity, reach, sustainability) and effectiveness (family satisfaction, staff knowledge and confidence implementing a palliative approach to care, hospital use).

Studieöversikt

Status

Aktiv, inte rekryterande

Detaljerad beskrivning

The SPA-LTC program has been developed and refined through prior participatory action based studies.

Evidence-based components of the program include:

Palliative Champion Teams; Palliative Care Education, including illness-trajectory pamphlets for staff and family members; Comfort Care Rounds with staff; Prognostic Tools to trigger end-of-life discussions; Palliative Care Conferences; Bereavement Pamphlets for families; and Post-Bereavement Follow-Up for families, and staff

The goal is to implement and assess this program across three provinces in Canada (Ontario, Saskatchewan, Manitoba). The investigators will use the findings to revise the program and inform the scaling up of the program across diverse settings and provinces.

Studietyp

Interventionell

Inskrivning (Beräknad)

594

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Manitoba
      • Winnipeg, Manitoba, Kanada
        • University of Manitoba
    • Ontario
      • Hamilton, Ontario, Kanada
        • McMaster University
    • Saskatchewan
      • Regina, Saskatchewan, Kanada
        • University of Regina
      • Saskatoon, Saskatchewan, Kanada
        • University of Saskatchewan

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn
  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • English-speaking LTC residents with a score of 50% or less on the Palliative Performance Scale.

Exclusion Criteria:

  • Non-English speaking LTC residents
  • residents with a score of more than 50% on the Palliative Performance Scale.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Hälsovårdsforskning
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Intervention

Within the intervention arm 9 long-term care homes will receive the SPA-LTC program:3 in Ontario; 3 in Saskatchewan and 3 in Manitoba.

Our team will work with long-term care homes in the study to implement the Strengthening a Palliative Approach in Long Term Care (SPA-LTC) which consists of the following core, evidence-informed components:

Palliative Champion Teams (to provide leadership and support implementation); Palliative Care Education (including illness trajectory pamphlets); Comfort Care Rounds with staff (for capacity building and reflection); Prognostic Tools to trigger end-of-life discussions; Palliative Care Conferences with families and residents; Bereavement Pamphlets; and Post-Bereavement Follow-Up for families, and staff.

Inget ingripande: Control

Within the control arm 9 long-term care homes will receive the standard of care: 3 in Ontario; 3 in Saskatchewan and 3 in Manitoba.

Vad mäter studien?

Primära resultatmått

Resultatmått
Tidsram
Antal akutmottagningsbesök under den boendes sista levnadsår
Tidsram: Alla boende i hemmet som avlidit ett år före genomförandet och ett år före dödsdatum för alla boende i hemmet som avlider under studiens interventionsperiod.
Alla boende i hemmet som avlidit ett år före genomförandet och ett år före dödsdatum för alla boende i hemmet som avlider under studiens interventionsperiod.

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Family Perceptions of End of Life Care
Tidsram: Survey completed at enrolment into the study; survey completed 2 months after the Family Care Conference or 1 month after the end of the intervention period if no Family Care Conference occurred.

Survey

Survey completed at enrolment into the study; survey completed 2 months after the Family Care Conference or 1 month after the end of the intervention period if no Family Care Conference occurred.
Family Experiences with End of Life Care
Tidsram: Interview completed at enrolment into the study; survey completed 2 months after the Family Care Conference or 1 month after the end of the intervention period if no Family Care Conference occurred.

Interview

Interview completed at enrolment into the study; survey completed 2 months after the Family Care Conference or 1 month after the end of the intervention period if no Family Care Conference occurred.
Staff Knowledge about a Palliative Approach to Care
Tidsram: All staff in all participating long-term care homes will complete a staff survey at 2 points in the study: at the beginning and the end of the intervention

Survey

All staff in all participating long-term care homes will complete a staff survey at 2 points in the study: at the beginning and the end of the intervention
Number of Hospital Transfers per Resident
Tidsram: Chart audit at start of the trial to capture data on residents who died in the year prior to the trial. Chart audits also during the transition phase prior to Steps 2 and 3; and one month after the intervention period for the trial ends.

Chart data at each study site will be audited to capture data on the number of hospital transfers in the last year of life for residents who died 1 year before the trial or who die during the trial.

Chart audit at start of the trial to capture data on residents who died in the year prior to the trial. Chart audits also during the transition phase prior to Steps 2 and 3; and one month after the intervention period for the trial ends.
Number of Hospital Deaths during the trial
Tidsram: Chart audit at start of the trial to capture data on residents who died in the year prior to the trial. Chart audits also during the transition phase prior to Steps 2 and 3; and one month after the intervention period for the trial ends.

Chart data at each study site will be audited to capture data on the number of hospital deaths in the year prior to the trial and during the trial.

Chart data at each study site will be audited to capture data on the number of hospital transfers in the residents last year of life.

Chart audit at start of the trial to capture data on residents who died in the year prior to the trial. Chart audits also during the transition phase prior to Steps 2 and 3; and one month after the intervention period for the trial ends.
Bereaved Family Satisfaction with End of Life Care
Tidsram: 6 weeks to 2 months after the resident's death

Qualitative interview with family members whose loved one died during the trial.

6 weeks to 2 months after the resident's death
Resident Satisfaction with End of Life Care
Tidsram: At the time of enrolment and 2 months after the Family Care Conference or 1 month after the intervention period if no Family Care Conference occurred.

Qualitative interview with residents who are enrolled in the trial

At the time of enrolment and 2 months after the Family Care Conference or 1 month after the intervention period if no Family Care Conference occurred.

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Fidelity of the Intervention
Tidsram: Checklist completed weekly during the intervention period for up to 160 weeks.

Checklist

Checklist completed weekly during the intervention period for up to 160 weeks.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 juni 2022

Primärt slutförande (Faktisk)

31 januari 2025

Avslutad studie (Beräknad)

31 januari 2028

Studieregistreringsdatum

Först inskickad

26 april 2019

Först inskickad som uppfyllde QC-kriterierna

1 maj 2019

Första postat (Faktisk)

2 maj 2019

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

6 oktober 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

5 oktober 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

There is no plan to make individual participant data (IPD) available to other researchers.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera